아바노스 메디컬, Inc.
US ˙ NYSE ˙ US05350V1061

SecurityAVNS / Avanos Medical, Inc.
InstitutionBrown Advisory Inc
Latest Disclosed Ownership2,231,198 shares
Latest Disclosed Value $ 31,259,092
Brown Advisory Inc reports 15.26% increase in ownership of AVNS / Avanos Medical, Inc.

On May 15, 2026 - Brown Advisory Inc filed a 13F-HR form disclosing ownership of 2,231,198 shares of Avanos Medical, Inc. (US:AVNS) valued at $31,259,084 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 1,935,802 shares of Avanos Medical, Inc.. This represents a change in shares of 15.26% during the quarter. The current value of the position is $55,779,950 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F AVANOS MED COM 05350V106 2,231,198 295,396 15.26 31,259 43.79 0.0514
2026-02-13 2025-12-31 13F AVANOS MED COM 05350V106 1,935,802 -290,954 -13.07 21,739 -15.55 0.0303
2025-11-14 2025-09-30 13F AVANOS MED COM 05350V106 2,226,756 417,921 23.10 25,741 16.26 0.0335
2025-08-13 2025-06-30 13F AVANOS MED COM 05350V106 1,808,835 -122,328 -6.33 22,140 -19.99 0.0291
2025-04-30 2025-03-31 13F AVANOS MED COM 05350V106 1,931,163 26,069 1.37 27,674 -8.76 0.0395
2025-02-14 2024-12-31 13F AVANOS MED COM 05350V106 1,905,094 204,218 12.01 30,329 -25.80 0.0385
2024-11-13 2024-09-30 13F AVANOS MED COM 05350V106 1,700,876 30,093 1.80 40,872 22.81 0.0513
2024-08-14 2024-06-30 13F AVANOS MED COM 05350V106 1,670,783 274,920 19.70 33,282 19.75 0.0435
2024-04-24 2024-03-31 13F AVANOS MED COM 05350V106 1,395,863 1,395,863 27,792 0.0372
2021-07-29 2021-06-30 13F AVANOS MED COM 05350V106 0 -5,148 -100.00 0 -100.00
2021-05-14 2021-03-31 13F AVANOS MED COM 05350V106 5,148 0 0.00 225 -4.66 0.0004
2021-02-12 2020-12-31 13F AVANOS MED COM 05350V106 5,148 5,148 236 0.0004
2020-02-14 2019-12-31 13F AVANOS MED COM 05350V106 0 -6,245 -100.00 0 -100.00
2019-11-14 2019-09-30 13F AVANOS MED COM 05350V106 6,245 -237 -3.66 234 -17.31 0.0007
2019-08-12 2019-06-30 13F AVANOS MED COM 05350V106 6,482 -106 -1.61 283 0.35 0.0008
2019-05-15 2019-03-31 13F AVANOS MED COM 05350V106 6,588 -273 -3.98 282 -8.44 0.0008
2019-02-13 2018-12-31 13F AVANOS MED COM 05350V106 6,861 22 0.32 308 -34.33 0.0010
2018-11-13 2018-09-30 13F AVANOS MED COM 05350V106 6,839 -100 -1.44 469 18.14 0.0013
2018-08-10 2018-06-30 13F HALYARD HEALTH COM 40650V100 6,939 131 1.92 397 26.43 0.0012
2018-06-28 2018-03-31 13F/A-1 HALYARD HEALTH COM 40650V100 6,808 69 1.02 314 0.96 0.0010
2018-05-14 2018-03-31 13F HALYARD HEALTH COM 40650V100 5,591 -1,148 258
2018-02-12 2017-12-31 13F HALYARD HEALTH COM 40650V100 6,739 -1,049 -13.47 311 -11.40 0.0010
2017-11-13 2017-09-30 13F HALYARD HEALTH COM 40650V100 7,788 -276 -3.42 351 10.38 0.0012
2017-08-14 2017-06-30 13F HALYARD HEALTH COM 40650V100 8,064 375 4.88 318 8.53 0.0010
2017-05-15 2017-03-31 13F HALYARD HEALTH COM 40650V100 7,689 -27 -0.35 293 2.45 0.0010
2017-02-13 2016-12-31 13F HALYARD HEALTH COM 40650V100 7,716 -246 -3.09 286 4.00 0.0010
2016-11-14 2016-09-30 13F HALYARD HEALTH COM 40650V100 7,962 64 0.81 275 7.42 0.0009
2016-08-09 2016-06-30 13F HALYARD HEALTH COM 40650V100 7,898 -70 -0.88 256 11.79 0.0009
2016-05-13 2016-03-31 13F HALYARD HEALTH COM 40650V100 7,968 7,968 229 0.0008
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.